Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 3395

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.46, p 0.214). This receipt's hash covers every field on it, plus the hash of receipt 3394, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 3395
    19 Oct 2026, 18:59 UTC

    HAPLN2

    oligodendrocytes, braak

    predictionHAPLN2 in oligodendrocytes tracks Braak Lewy-body stage

    registered885a1a1cd00277a5

    discovery+0.46 p=0.214 n=9

    replication-0.27 p=0.487 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.46, p 0.214)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    0b0310fa5e50488fa744ee98…
    follows 9e9b2d348356…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 3395: HAPLN2 in oligodendrocytes, braak

power
full sample +0.01 (p 0.983, n 18), 95% CI -0.46 to +0.47. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.02 (p 0.949, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.16 (p 0.521, n 18). could be the mix.
skeptic
leave-one-out range -0.11 to +0.13, sign flips 11; without severely affected donors +0.01 (p 0.983, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for HAPLN2 in oligodendrocytes.

case closed: nothing better to follow up.